Lifecore Biomedical Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	May '25 May 25, 2025	May '24 May 26, 2024	May '23 May 28, 2023	May '22 May 29, 2022	May '21 May 30, 2021
Revenue	127.36	128.87	128.26	103.27	111.27	100.87
Revenue Growth (YoY)	-2.27%	0.47%	24.20%	-7.19%	10.31%	-36.98%
Cost of Revenue	87.98	88.57	86.41	75.28	72.2	61.94
Gross Profit	39.37	40.3	41.85	27.99	39.07	38.94
Selling, General & Admin	38.11	44.05	40.46	38.97	34.66	27.72
Research & Development	7.29	8.26	8.58	8.74	7.84	6.68
Other Operating Expenses	-2.43	5.24	1.66	2.08	8.36	13.36
Total Operating Expenses	42.97	57.54	50.69	49.78	50.86	47.76
Operating Income	-10.33	-17.25	-8.84	-21.8	-11.79	-8.82
Interest Income	0.3	-	-	-	-	0.05
Interest Expense	-23.82	-21.84	-18.09	-17.58	-15.47	-8.93
Other Non-Operating Income (Expense)	-3.51	0.41	36.45	-24.55	6.57	-12.08
Total Non-Operating Income (Expense)	-27.19	-21.43	18.36	-42.13	-8.9	-20.96
Pretax Income	-37.36	-38.67	9.51	-63.93	-20.69	-29.79
Provision for Income Taxes	-0.11	-0.04	-0.18	-0.31	5.21	6.35
Net Income	-44.06	-44.36	12.01	-99.56	-117.41	-23.44
Net Income Attributable to Preferred Dividends	6.6	5.64	-	-	-	-
Earnings From Discontinued Operations	-	-	2.68	-35.33	-101.93	-
Net Income to Common	-44.06	-44.36	12.01	-99.56	-117.41	-23.44
Shares Outstanding (Basic)	36	35	30	30	29	29
Shares Outstanding (Diluted)	36	35	37	30	29	29
Shares Change (YoY)	4.78%	-5.02%	22.36%	1.67%	0.59%	0.45%
EPS (Basic)	-1.16	-1.27	0.39	-3.32	-3.97	-1.10
EPS (Diluted)	-1.16	-1.27	0.33	-3.32	-3.97	-1.10
Shares Outstanding	37.48	37.03	30.56	30.32	29.51	29.33
Free Cash Flow	-5.98	-13.62	-18.14	-38.92	-52.53	-8.75
Free Cash Flow Per Share	-0.16	-0.39	-0.49	-1.30	-1.78	-0.30
Gross Margin	30.92%	31.27%	32.63%	27.10%	35.11%	38.60%
Operating Margin	-8.11%	-13.38%	-6.90%	-21.11%	-10.60%	-8.75%
Profit Margin	-29.35%	-30.04%	7.28%	-62.20%	-13.91%	-23.23%
FCF Margin	-4.69%	-10.57%	-14.14%	-37.69%	-47.21%	-8.68%
EBITDA	-1.99	-9.22	-0.89	-8.62	6.27	11.04
EBITDA Margin	-1.56%	-7.15%	-0.69%	-8.35%	5.63%	10.95%
EBIT	-10.33	-17.25	-8.84	-21.8	-11.79	-8.82
EBIT Margin	-8.11%	-13.38%	-6.90%	-21.11%	-10.60%	-8.75%
Effective Tax Rate	0.30%	0.11%	-1.92%	0.48%	-25.19%	-21.32%

Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q